References:
- Leon MB, Smith CR, Mack M et al; PARTNER Trial Investigators.
Transcatheter aortic-valve implantation for aortic stenosis in
patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.
- Joint Task Force on the Management of Valvular Heart Disease of the
European Society of Cardiology (ESC); European Association for
Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F et
al. Guidelines on the management of valvular heart
disease (version 2012). Eur Heart J. 2012;33:2451-96.
- Nishimura RA, Otto CM, Bonow RO et al; American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines. 2014 AHA/ACC guideline for the management of patients with
valvular heart disease: executive summary: a report of the American
College of Cardiology/American Heart Association Task Force on
Practice Guidelines. J Am Coll Cardiol 2014;63: 2438–88.
- Puri R, Iung B, Cohen DJ, Rodés-Cabau J. TAVI or No TAVI: identifying
patients unlikely to benefit from transcatheter aortic valve
implantation. Eur Heart J . 2016;37:2217-25.
- Dubois C, Coosemans M, Rega F et al. Prospective evaluation of
clinical outcomes in all-comer high-risk patients with aortic valve
stenosis undergoing medical treatment, transcatheter or surgical
aortic valve implantation following heart team assessment.Interact Cardiovasc Thorac Surg . 2013;17:492-500.
- Kaier K, Gutmann A, Vach W et al. “Heart Team” decision making in
elderly patients with symptomatic aortic valve stenosis who underwent
AVR or TAVI – a look behind the curtain. Results of the prospective
TAVI Calculation of Costs Trial (TCCT). EuroIntervention .
2015;11:793-8.
- Meyer SR, Shanks M, Tyrrell BD et al. Outcomes of consecutive patients
referred for consideration for transcatheter aortic valve implantation
from encompassing health-care region. Am J Cardiol. 2013;112:1450-4.
- Kappetein AP, Head SJ, Généreux P et al; Valve Academic Research
Consortium (VARC)-2 Updated standardized endpoint definitions for
transcatheter aortic valve implantation: the Valve Academic Research
Consortium-2 consensus document. Eur Heart J . 2012; 33:2403-18
- Schumacher M, Holländer N, Schwarzer G, Binder H, Sauerbrei W.
Prognostic Factor Studies. In: Crowley J, Hoering A, editors.Handbook of Statistics in Clinical Oncology . 3 ed. Boca Raton:
CRC Press; 2012. p.415-69.
- Serruys PW, Morice MC, Kappetein AP et al; SYNTAX Investigators.
Percutaneous Coronary Intervention versus Coronary-Artery Bypass
Grafting for Severe Coronary Artery Disease. N Engl J Med .
2009;360:961–72.
- Smith CR, Leon MB, Mack MJ, PARTNER Trial Investigators. Transcatheter
versus surgical aortic-valve replacement in high-risk patients.N Engl J Med 2011;364:2187–98.
- Coylewright M, Mack MJ, Holmes DR, O‘Gara PT. A call for an
evidence-based approach to the Heart Team for patients with severe
aortic stenosis. J Am Coll Cardiol . 2015;65:1472-80.
- Mack MJ, Leon MB, Thourani VH et al; PARTNER 3 Investigators.
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve
in Low-Risk Patients. N Engl J Med . 2019;380:1695-705.
- Popma JJ, Deeb GM, Yakubov SJ et al; Evolut Low Risk Trial
Investigators. Transcatheter Aortic-Valve Replacement with a
Self-Expanding Valve in Low-Risk Patients. N Engl J Med2019;380:1706-15.
- Iung B, Cachier A, Baron G et al. Decision-making in elderly patients
with severe aortic stenosis: why are so many denied surgery? Eur
Heart J 2005; 26: 2714-20.
- Nombela-Franco L, Ribeiro HB, Urena M et al. Significant mitral
regurgitation left untreated at the time of aortic valve replacement:
a comprehensive review of a frequent entity in the transcatheter
aortic valve replacement era. J Am Coll Cardiol2014;63:2643-58.
- Bedogni F, Latib A, De Marco F et al. Interplay Between Mitral
Regurgitation and Transcatheter Aortic Valve Replacement With the
CoreValve Revalving System: A Multicenter
Registry. Circulation 2013;128:2145–53.
- Nombela-Franco L, Eltchaninoff H, Zahn R et al. Clinical impact and
evolution of mitral regurgitation following transcatheter aortic valve
replacement: a meta-analysis. Heart 2015;101:1395-405.
- Barreiro CJ, Patel ND, Fitton TP et al. Aortic valve replacement and
concomitant mitral valve regurgitation in the elderly: impact on
survival and functional outcome. Circulation 2005;112:I443–7.
- Ruel M, Kapila V, Price J, Kulik A, Burwash IG, Mesana TG. Natural
history and predictors of outcome in patients with concomitant
functional mitral regurgitation at the time of aortic valve
replacement. Circulation 2006;114:I541–6.
- Litmathe J, Boeken U, Kurt M, Feindt P, Gams E. Predictive risk
factors in double-valve replacement (AVR and MVR) compared to isolated
aortic valve replacement. Thorac Cardiovasc Surg2006;54:459-63.
- Afilalo J, Mottillo S, Eisenberg MJ et al. Addition of frailty and
disability to cardiac surgery risk scores identifies elderly patients
at high risk of mortality or major morbidity. Circ Cardiovasc
Qual Outcomes 2012;5:222–8.
- Sundermann S, Dademasch A, Rastan A et al. One-year follow-up of
patients undergoing elective cardiac surgery assessed with the
comprehensive assessment of frailty test and its simplified
form. Interact Cardiovasc Thorac Surg 2011; 13: 119–23
- Green P, Woglom AE, Genereux P. The impact of frailty status on
survival after transcatheter aortic valve replacement in older adults
with severe aortic stenosis: a single-center experience. JACC
Cardiovasc Interv 2012;5:974–81
- Lindman BR, Alexander KP, O’gara PT, Afilalo J. Futility, benefit, and
transcatheter aortic valve replacement. JACC Cardiovasc Interv 2014;7:707–16.
- Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P.
Aortic valve calcification in chronic kidney disease. Nephrology
Dialysis Transplantation 2013;28:2968-76.
- Kumar N, Khera R, Garg N et al. Comparison of Outcomes of
Transcatheter Versus Surgical Aortic Valve Replacement in Patients
With Chronic Kidney Disease. Am J Cardiol 2018;121:343-8.
- Leon MB, Smith CR, Mack MJ et al; PARTNER 2 Investigators.
Transcatheter or surgical aortic-valve replacement in
intermediate-risk patients. N Engl J Med 2016;374:1609–20.
- Makkar RR, Fontana GP, Jilaihawi H et al; PARTNER Trial Investigators.
Transcatheter aortic-valve replacement for inoperable severe aortic
stenosis. N Engl J Med 2012;366:1696–704.